Blogs about Biotechnology, Pharmaceutical and Healthcare

16:38 EST 21st December 2014 | BioPortfolio

Read the latest opinions - blogs from pharmaceutical and life science industry experts.

Showing News Articles 1–25 of 67,000+

Sunday 21st December 2014

Animals that want to survive use time management skills

Many animals may have a previously under-appreciated ability to make up for lost time with more effort, according to new research publishing this week in PLOS Computational Biology. This capability could help scientists better understand how animals...

Don’t pay specialists for being on call. Here’s why.

Every ER has its call roster, that sacred list of oracles, laying out who we can call when our patients need some service that we cannot provide. If I need a cardiologist, or a neurosurgeon or even a dermatologist for some acute emergency condition, all I need to do is ring up the operator and […]

Update: Ligand Wins EU Approval For Duavive

Creative Edge Makes Front Page Canadian National News

Public health work is my serenity prayer

Three days after finishing my residency, I became the medical director of the community health center where I had taken my first job.  It forever changed, and probably saved, my career. The risk of burnout hit me early. While I loved patient care, I also found the stress, the lack of control of my time, […]

Saturday 20th December 2014

Escaping the curse of experience, for just one moment

It’s a strange thing to be driving about in your car in the middle of the day.  For one who has spent the majority of his professional life sheltered in dark offices and aseptic hospitals, the summer sun and fresh breeze is quite lovely.  One almost begins to approach humanness.  Normal.  This must have been […]

Can scientists clone a rhinoceros?

San Diego-based team aims to create rhino sperm and embryos from specialized stem cells.

Some Outreach Test Results Are Bypassing Hospital LISs; A Growing Trend?

In my last two notes, I have been discussing the potentially disruptive effect of the Theranos business model, particularly with reference to Quest Diagnostics and Lab Corp (see: Finally, Some Important New Details about the Theranos Business Model; ...

Ono and Gilead in ONO-4059 licensing pact

Ono Pharmaceutical and Gilead Sciences have entered into an exclusive license agreement for the development and commercialization of ONO-4059, ONO’s oral Bruton’s tyrosine kinase (BTK) inhibitor for the treatment of B-cell malignancies and other diseases. Gilead will pay ONO an upfront payment plus additional payments based upon achievement of certain development, regulatory and commercial mil...

Roche acquires Bina and Dutalys in festive shopping spree

Roche has agreed to acquire Dutalys and Bino Technologies in a end of year acquisition push. Searching for more deal information? Current Partnering offers the following options: CP Reports | Browse titles | Over 200 report titles that focus upon different deal types from licensing, co-promotion to distribution, biomarkers to drug delivery, oncology to psychiatry, all more » The post R...

Juno Therapeutics lands bumper $265 million IPO

Juno Therapeutics announced the pricing of its initial public offering of 11,022,917 shares of common stock at a price to the public of $24.00 per share. In addition, Juno Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,653,437 shares of common stock to cover over-allotments, if any. Searching for more » The post Juno Therapeutics lands bumper $265 mill...

Medovex seeks $80 million IPO

Medovex has priced its initial public offering of 1,391,305 units, each unit consisting of one share of common stock and one Series A Warrant, at a price to the public of $5.75 per unit. The units are expected to begin trading on The NASDAQ Capital Market on December 19, 2014 under the ticker symbol “MDVXU.” more » The post Medovex seeks $80 million IPO appeared first on .

CardioDx raises $35 million for COPD development

CardioDx announced the close of $35 million in total equity financing. Alberta Investment Management Corporation (AIMCo) participated in this round together with the company’s existing investors. Searching for more deal information? Current Partnering offers the following options: CP Reports | Browse titles | Over 200 report titles that focus upon different deal types from licensi...

Ascendis files for $86 million IPO

Ascendis Pharma will go public, raising up to $86 million towards an IPO, one of the largest for a biotech company this year. Searching for more deal information? Current Partnering offers the following options: CP Reports | Browse titles | Over 200 report titles that focus upon different deal types from licensing, co-promotion to distribution, biomarkers to more » The post Ascendis f...

Delivering drugs on demand

Current drug-delivery systems used to administer chemotherapy to cancer patients typically release a constant dose of the drug over time - but a new study challenges this "slow and steady" approach and offers a novel way to locally deliver the drugs ...

Shortening medical school: Is that a good idea?

Why are we shortening medical degrees? The four-year medical degree has been the mainstay of U.S. medical schools for more than a century, following the publication of the Flexner report in 1910. Prior to this, there was little standardization about what a medical degree could or should look like. Medical school education was subsequently standardized […]

We Spend More on Health Care Than Other Rich Countries but Have Worse Outcomes?

By FRANK de LIBERO Here it’s argued that we need to retire the health care fallacy, “We spend more on health care than other rich countries but have worse outcomes.” The fallacy implies U.S. health care is deficient in spite of being costly. In...

antibodies from llamas might help in the fight against HIV/AIDS

Most vaccines work by inducing an immune response characterized by neutralizing antibodies against the respective pathogen. An effective HIV vaccine has remained elusive so far, but researchers have continued to make progress, often employing innovat...

AIDS Drug Also Offers Protection Against Malaria

Children with HIV/AIDS in Africa are at a higher-than-average risk for another deadly disease: malaria. But a team of Yale School of Public Health researchers has discovered that people taking […]

Knee meniscus fixed using revolutionary stem cell procedure

Researchers report on a revolutionary new procedure that uses 3-D printing and the body’s stem cells to regenerate knee meniscus, a tissue lining that acts as a natural cushion between […]

Study: Industrial clusters fuel economies

New study shows clusters, across fields, help growth, jobs, and innovation. Experts have long theorized that having a cluster of firms within a given industry helps a region’s economy grow. […]

Ibuprofen could be an anti-aging medicine

Ibuprofen, a common over-the-counter drug used to relieve pain and fever, could hold the keys to a longer healthier life, according to a study by researchers at the Buck Institute for Research on Aging. Publishing in PLoS Genetics on December 18th, ...

Gilead: What's Ahead In 2015 For This Biotech Juggernaut

A day in the life of a hospitalist

I am a young hospitalist who is 16 months into my role at an urban academic medical center. Unlike many of my more-senior colleagues who found their way to hospital medicine by circumstance, luck, or as a second-career path, I have been planning my career in hospital medicine since the beginning of my residency training. […]

News digest – Government science funding, exercise and prostate cancer, drug approval and more

Government science funding announcement, exercise and prostate cancer, plus a handful of stories about drug approval - here’s the week’s cancer news.

Search BioPortfolio: